In the clinical setting, DM is commonly separated into two major forms, type-one diabetes (T1D) defined by the immune-mediated destruction of insulin-producing beta-cells in the pancreas, causing insulin deficiency, and T2D, traditionally explained by metabolic determinants and the low sensitivity of cells and tissues to insulin, the phenomenon called peripheral insulin resistance [8]. This evidence concerns the gene INS and Insulin resistance.